Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the carvedilol or metoprolol european trial (COMET): randomized controlled trial

By Poole-Wilson P.A.   Swedberg K.   Cleland J.G.F.   for the COMET Investigators  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 45-45

Elsevier

Access to resources Recommend Favorite

How Should Subgroup Analyses Affect Clinical Practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF)

By Wikstrand J.  

Cardiac Electrophysiology Review, Vol. 7, Iss. 3, 2003-09 ,pp. : 264-275

Springer Publishing Company

Access to resources Recommend Favorite

Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS Trial): randomized controlled trial

By Cleland J.G.F.   Pennell D.J.   Ray S.G.   CHRISTMAS Carvedilol Hibernating Reversible Ischemia Trial Marker of Success Investigators  

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 42-42

Elsevier

Access to resources Recommend Favorite

Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?

By Khand A.U.   Rankin A.C.   Martin W.   Taylor J.   Gemmell I.   Cleland J.G.F.  

Journal of the American College of Cardiology, Vol. 42, Iss. 11, 2003-12 ,pp. : 1944-1951

Elsevier

Access to resources Recommend Favorite

Efficacy of carvedilol in pediatric heart failure

By Christensen Alex Hørby   Fatkin Diane  

Future Cardiology, Vol. 9, Iss. 4, 2013-07 ,pp. : 475-478

Future Medicine

Access to resources Recommend Favorite